Join Dr. Jace and Dr. Addy in this comprehensive episode of The Functional Code as they explore the highly debated topics of GMO versus non-GMO foods, and organic versus non-organic crops. Delving deep into the science, they discuss the impact on pain, performance, and longevity, while also shining a light on the roles of governing bodies like the USDA, FDA, and EPA. Learn about the health implications of GMOs, the benefits of organic farming, and the controversies around glyphosate and its potential risks, including the numerous lawsuits faced by Bayer. This episode aims to empower you with the knowledge to make more informed dietary choices and understand the broader environmental implications.Episode 55Dr. Jace Nybo D.C.Dr. Addy Knutson D.C.Guide:00:00 Intro02:04 Understanding GMOs and Their Impact02:52 Organic vs Non-Organic: Key Differences04:17 Regulatory Bodies and Their Roles06:26 Public Perception and Studies on GMOs07:18 Real-Life Experiences and Concerns08:52 The Role of Pesticides in GMO Crops12:34 Benefits and Risks of GMO Crops18:35 Global Perspectives on GMOs26:09 The Power of Big Food and Pharma30:19 Scientific Studies and Nutritional Comparisons36:00 The Impact of Soil and Pesticides38:03 Economic Implications of GM Crops38:32 Seed Dependency and Legal Issues42:41 Organic vs. Non-Organic: Health Benefits45:35 Allergenicity of GMOs51:24 The Wheat and Gluten Debate59:04 Glyphosate: Health Implications and Legal Battles01:10:05 Final Thoughts and Call to ActionResources:-doi.org/10.1186/s12302-021-00578-9-doi.org/10.1007/s12161-022-02435-8-centerforfoodsafety.org-https://www.who.int/news-room/questions-and-answers/item/food-genetically-modified?utm_source-https://geneticliteracyproject.org/gmo-faq/why-are-there-no-long-term-gmo-safety-studies-or-studies-on-humans/?utm_source=-DOI: 10.1053/j.jvca.2017.06.008-DOI: 10.1007/978-1-62703-023-6_8-DOI: 10.1186/s12939-017-0581-3-DOI: 10.1016/j.ultramic.2014.05.010-DOI: 10.1016/S0140-6736(12)60734-X-DOI: 10.1111/j.1537-2995.2009.02244.x-DOI: 10.3390/ijerph110404449-DOI: 10.1155/2019/2905615-DOI: 10.1017/S0007114514001366-DOI: 10.7326/0003-4819-157-5-201209040-00007-DOI: 10.1371/journal.pone.0035881-DOI: 10.1097/WON.0b013e318264c3a0-PMID: 24892316-DOI: 10.1107/S1600536811017910-DOI: 10.1165/rcmb.2013-0404OC-DOI: 10.1016/j.jconrel.2019.06.038-DOI: 10.1016/j.psyneuen.2018.02.003-DOI: 10.1016/j.amepre.2017.03.005-DOI: 10.1136/bmjqs-2016-006028-DOI: 10.1155/2018/9157089-DOI: 10.1016/j.jsb.2015.06.018-DOI: 10.1016/j.cardfail.2015.06.010-DOI: 10.1021/acs.jafc.0c02815-einkorn.com-doi.org/10.3390/ijms24065453-doi.org/10.1007/s10142-018-0632-x-https://www.reuters.com/legal/bayer-must-pay-78-mln-latest-roundup-cancer-trial-jury-finds-2024-10-10/📲Instagram: instagram.com/thefunctionalcode/📲TicTock: @thefunctionalcode📲Apple Podcast: podcasts.apple.com/us/podcast/the-functional-code-podcast/id1754585557

Ver todos los episodios